dolutegravir (tivicay): a next generation integrase inhibitor
Published 10 years ago • 8.3K plays • Length 16:18Download video MP4
Download video MP3
Similar videos
-
14:27
dolutegravir-rilpivirine (juluca)
-
19:12
tolerability of dolutegravir and the other insti’s
-
16:27
dolutegravir: pros and cons (are there any cons?)
-
14:50
resistance to integrase strand transfer inhibitors
-
15:45
do integrase inhibitors cause weight gain?
-
50:56
the future of antiretroviral therapy - new agents and strategies
-
15:13
antiretroviral therapy guidelines
-
30:07
croi 2017 highlightswhat’s new in antiretrovirals (part 2)
-
5:34
dolutegravir rilpivirine combination therapy for hiv
-
2:59
real world tandem asct for high risk mm
-
15:24
second line therapy
-
7:55
mini-lecture series: dolutegravir-rilpivirine
-
![#vaccinatesg: dr t. ravintharan [english]](https://i.ytimg.com/vi/sHQHG5MT8JI/mqdefault.jpg)
3:32
#vaccinatesg: dr t. ravintharan [english]
-
2:23
about adaptiiv medical technologies inc.
-
18:06
hiv cure & antiretrovials
-
0:45
cys-ser mutation-driven ibrutinib resistance and alternative btki’s under development
-
1:09
john koo, md - does a patient with latent tb need treatment before using ruxolitinib cream?
-
0:58
what is the biomedical hiv prevention implant being developed by rti?
-
30:17
acute side effects from antiretroviral medication